Clavamox is an orally administered formulation comprised of the broad-spectrum antibiotic amoxicillin trihydrate and the Beta-lactamase inhibitor clavulanate potassium (the potassium salt of clavulanic acid). 
Each unreconstituted bottle contains 750 mg of amoxicillin and 187.5 mg of clavulanic acid.